JPH0613519B2 - 薬学的処方物 - Google Patents

薬学的処方物

Info

Publication number
JPH0613519B2
JPH0613519B2 JP60076904A JP7690485A JPH0613519B2 JP H0613519 B2 JPH0613519 B2 JP H0613519B2 JP 60076904 A JP60076904 A JP 60076904A JP 7690485 A JP7690485 A JP 7690485A JP H0613519 B2 JPH0613519 B2 JP H0613519B2
Authority
JP
Japan
Prior art keywords
nedocromil sodium
water
sodium
nedocromil
propellant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP60076904A
Other languages
English (en)
Japanese (ja)
Other versions
JPS60231680A (ja
Inventor
ケネス・ブラウン
アンドルー・レジナルド・クラーク
リチヤード・サリス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848409705A external-priority patent/GB8409705D0/en
Priority claimed from GB848423634A external-priority patent/GB8423634D0/en
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of JPS60231680A publication Critical patent/JPS60231680A/ja
Publication of JPH0613519B2 publication Critical patent/JPH0613519B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP60076904A 1984-04-13 1985-04-12 薬学的処方物 Expired - Lifetime JPH0613519B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB848409705A GB8409705D0 (en) 1984-04-13 1984-04-13 Pharmaceutical formulation
GB8409705 1984-04-13
GB8423634 1984-09-19
GB848423634A GB8423634D0 (en) 1984-09-19 1984-09-19 Pharmaceutical formulation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP5179507A Division JPH0798749B2 (ja) 1984-04-13 1993-07-21 エアゾール剤

Publications (2)

Publication Number Publication Date
JPS60231680A JPS60231680A (ja) 1985-11-18
JPH0613519B2 true JPH0613519B2 (ja) 1994-02-23

Family

ID=26287614

Family Applications (2)

Application Number Title Priority Date Filing Date
JP60076904A Expired - Lifetime JPH0613519B2 (ja) 1984-04-13 1985-04-12 薬学的処方物
JP5179507A Expired - Lifetime JPH0798749B2 (ja) 1984-04-13 1993-07-21 エアゾール剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP5179507A Expired - Lifetime JPH0798749B2 (ja) 1984-04-13 1993-07-21 エアゾール剤

Country Status (22)

Country Link
US (2) US4760072A (enExample)
EP (1) EP0162556B1 (enExample)
JP (2) JPH0613519B2 (enExample)
AU (1) AU584329B2 (enExample)
BE (1) BE902185A (enExample)
CA (1) CA1257201A (enExample)
CH (1) CH667271A5 (enExample)
DE (1) DE3584580D1 (enExample)
DK (1) DK174429B1 (enExample)
ES (1) ES8800668A1 (enExample)
FI (1) FI90942C (enExample)
FR (1) FR2563105B1 (enExample)
GB (1) GB2157291B (enExample)
GR (1) GR850916B (enExample)
IE (1) IE57653B1 (enExample)
IL (1) IL74883A (enExample)
LU (1) LU85850A1 (enExample)
MY (1) MY100428A (enExample)
NO (1) NO172542C (enExample)
NZ (1) NZ211771A (enExample)
PT (1) PT80275B (enExample)
SA (1) SA94150322B1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260306A (en) * 1981-07-24 1993-11-09 Fisons Plc Inhalation pharmaceuticals
EP0150966B1 (en) * 1984-01-26 1989-07-12 FISONS plc Benzopyran derivatives, compositions containing them and processes for their preparation
GB2187953B (en) * 1986-03-15 1989-11-15 Fisons Plc Pharmaceutical formulation
DE3787274T2 (de) * 1986-12-23 1994-01-27 Fisons Plc Pharmazeutische Präparate, die eine wässerige Lösung eines Pyranoquinolins enthalten.
USRE38628E1 (en) * 1986-12-23 2004-10-19 Fisons Plc Pharmaceutical compositions
GB8704089D0 (en) * 1987-02-21 1987-03-25 Fisons Plc Method of treatment
GB8704773D0 (en) * 1987-02-28 1987-04-01 Fisons Plc Compounds
GB2202145B (en) * 1987-03-17 1991-01-02 Fisons Plc Compositions of nedocromil for dermatological use.
GB8712251D0 (en) * 1987-05-23 1987-07-01 Fisons Plc Formulation
GB8727590D0 (en) * 1987-11-25 1987-12-31 Fisons Plc Formulation
GB8820267D0 (en) * 1988-08-26 1988-09-28 Fisons Plc Pharmaceutical formulation
US5248493A (en) * 1988-08-27 1993-09-28 Fisons Plc Pharmaceutical composition
GB8820398D0 (en) * 1988-08-27 1988-09-28 Fisons Plc Pharmaceutical formulation
US5198221A (en) * 1989-05-17 1993-03-30 Fisons Plc Pharmaceutical composition
GB8911259D0 (en) * 1989-05-17 1989-07-05 Fisons Plc Inhalation medicament
US5195287A (en) * 1990-03-19 1993-03-23 Bemis Manufacturing Company Panel and method of making the same
US5952353A (en) * 1997-09-19 1999-09-14 Auburn University Treating/preventing heart failure via inhibition of mast cell degranulation
US6140348A (en) * 1997-09-19 2000-10-31 Auburn University Treating/preventing heart failure via inhibition of mast cell degranulation
GB9806462D0 (en) * 1998-03-26 1998-05-27 Glaxo Group Ltd Improved compositions for inhalation
AU2001283438A1 (en) * 2000-08-21 2002-03-04 Aeropharm Technology Incorporated A method of stabilizing a dry powder pharmaceutical formulation
US20050026880A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a cromone for treatment of asthma or chronic obstructive pulmonary disease
KR100550556B1 (ko) * 2003-11-11 2006-02-10 엘지전자 주식회사 에어컨의 중앙제어 시스템 및 그 동작방법
US9132116B2 (en) * 2004-08-02 2015-09-15 Willowcroft Pharm Inc. Mast cell stabilizers to prevent or treat laminitis
FR2898284B1 (fr) * 2006-03-10 2009-06-05 Inst Francais Du Petrole Procede de desacidification d'un gaz par solution absorbante avec regeneration fractionnee par chauffage.
TW200906777A (en) 2007-04-12 2009-02-16 Dow Global Technologies Inc Reducing heavy byproduct formtion during recovery of dichlorohydrins

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA782473B (en) * 1977-05-04 1979-04-25 Fisons Ltd Benzo pyrano-quinolinones
IL54614A (en) * 1977-05-04 1983-07-31 Fisons Ltd Dihydrodioxo-pyranoquinoline dicarboxylic acid derivatives,their production and pharmaceutical compositions containing them
FR2440371A1 (fr) * 1978-10-31 1980-05-30 Fisons Ltd Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer
ZM8479A1 (en) * 1978-10-31 1980-09-22 Fisons Ltd Compounds
EP0150966B1 (en) * 1984-01-26 1989-07-12 FISONS plc Benzopyran derivatives, compositions containing them and processes for their preparation

Also Published As

Publication number Publication date
JPH06227981A (ja) 1994-08-16
ES8800668A1 (es) 1987-11-16
FI90942B (fi) 1994-01-14
IL74883A (en) 1990-08-31
MY100428A (en) 1990-09-29
DK160985D0 (da) 1985-04-10
FR2563105A1 (fr) 1985-10-25
IE850938L (en) 1985-10-13
AU584329B2 (en) 1989-05-25
SA94150322B1 (ar) 2004-08-31
PT80275A (en) 1985-05-01
BE902185A (fr) 1985-07-31
NZ211771A (en) 1988-10-28
IE57653B1 (en) 1993-02-10
FI90942C (fi) 1994-04-25
GB2157291A (en) 1985-10-23
JPS60231680A (ja) 1985-11-18
FI851463L (fi) 1985-10-14
NO851475L (no) 1985-10-14
NO172542B (no) 1993-04-26
US4918078A (en) 1990-04-17
CH667271A5 (fr) 1988-09-30
JPH0798749B2 (ja) 1995-10-25
PT80275B (pt) 1987-10-20
AU4094285A (en) 1985-10-17
CA1257201A (en) 1989-07-11
GB2157291B (en) 1988-08-10
GR850916B (enExample) 1985-11-25
NO172542C (no) 1993-08-04
ES542184A0 (es) 1987-11-16
DK174429B1 (da) 2003-03-03
GB8508782D0 (en) 1985-05-09
EP0162556B1 (en) 1991-11-06
DE3584580D1 (de) 1991-12-12
FR2563105B1 (fr) 1987-02-13
LU85850A1 (fr) 1985-12-16
FI851463A0 (fi) 1985-04-12
US4760072A (en) 1988-07-26
DK160985A (da) 1985-10-14
EP0162556A1 (en) 1985-11-27

Similar Documents

Publication Publication Date Title
JPH0613519B2 (ja) 薬学的処方物
RU2148992C1 (ru) Способ кондиционирования веществ
DE2703119C2 (enExample)
EP0526171A2 (en) Crystals of N-(trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanine and methods for preparing them
JPH0714880B2 (ja) エアゾル用に適するよう物理的に修正されたベクロメタソンジプロピオネ−ト
JPH04266872A (ja) 複素環式化合物
CA1075228A (en) Flunisolide to treat respiratory diseases
WO1988007855A1 (en) Pharmaceutical compositions containing pentamidine
JPH0644994B2 (ja) ゲル組成物及びその製法
RS57551B1 (sr) Mikronizovani kristalni tiotropium bromid
JP4592955B2 (ja) 微粉砕医薬物質を製造するための粉砕方法
GB2196254A (en) Nedocromil sodium formation
JPS63225380A (ja) ネドクロミルカルシウム
CA1195975A (en) Steroid monohydrates, formulations containing same and method
KR101005717B1 (ko) 무수물의 ｈｆａ-현탁 제형
JP2005529087A (ja) 抗コリン作用薬含有ｈｆａ懸濁製剤
US4933168A (en) Stable, crystalline flunisolide
JP2005535577A (ja) 医学的に有効な成分の結晶の製造法、この方法によって得られた結晶および得られた結晶の医薬製剤における使用
CN1014521B (zh) 新型那多克罗眠耳纳盐及其药剂的制备方法
JPS6411615B2 (enExample)
JPS5916820A (ja) 無晶形マロチラ−トを含有する固形製剤組成物
Kumar et al. Improved hydrosolubility and rate of dissolution of famotidine by hydrotropism
JP2016193864A (ja) アスコルビン酸分散材、及びその製造方法
JPH0246020B2 (enExample)

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term